Summary The absorption and elimination of cefquinome in serum and tissues of coho salmon were studied. The study was performed in freshwater at 10°C with fish weighing 100 ± 5g (mean and standard deviation). Single doses of 5, 10 and 20 mg/kg were administered intraperitoneally to 30 fish for each dose. The maximum concentration occurred in the following order; kidney and liver > serum > muscle > brain. The pharmacokinetic analysis and predictive withdrawal times were calculated using only the dose of 20 mg/kg body weight. The peak cefquinome concentrations (Cmax) in serum (3.35 ± 0.45 μg/ml) and muscle (2.87 ± 0.53 μg/g) were achieved at 12h. In the brain, the Cmax was 2.18 μg/g at 6h. The halflives (t1/2) in serum, muscle, brain, liver and kidney were 20.56, 8.93, 9.35, 113.61 and 119.48 h, respectively. With the detection limit of 0.015 μg/g for the cefquinome, the predicted withdrawal time with 95% confidence for muscle tissue was 104.2 h at 10 °C for the 20 mg/kg dose. The results suggest that cefquinome could be efficacious and safe for the consumer in treating bacterial diseases of coho salmon in fresh water. Nevertheless, future studies are required in order to determine an adequate dose with the corresponding withdrawal times.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.